Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
baby calendar, Last Fiscal Year's Ordinary Profit Exceeds Expectations, 60% Increase in Ordinary Profit for The Current Fiscal Year
7363 baby calendar Inc. 【J-GAAP】
Earnings Reportbaby calendar Inc. <7363> [TSE Growth] announced its financial results after the market closed on February 14th (17:00). The ordinary profit/loss (non-consolidated) for the fiscal year ending December 2024 turned into a profit of 47 million yen (compared to a loss of 26 million yen in the previous period), exceeding the previous forecast of 6 million yen. In the fiscal year ending December 2025, the ordinary profit is expected to expanded to 59.6% to 75 million yen.
In the most recent three-month period, from October to December (4Q), the ordinary profit/loss turned to a profit of 17 million yen (compared to a loss of 16 million yen in the same period last year). The operating profit/loss margin drastically improved from -4.1% in the same period last year to 4.8%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2022 | 1,084 | 38 | 36 | 21 | 22.9 | 0 | Feb 14, 2023 | J-GAAP |
Dec, 2023 | 1,203 | -31 | -26 | -100 | -111.5 | 0 | Feb 14, 2024 | J-GAAP |
Dec, 2024 | 1,528 | 50 | 47 | 17 | 19.4 | 0 | Feb 14, 2025 | J-GAAP |
YoY | +27.0% | - | - | - | - |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2024 Guidance | 1,407 | 9 | 6 | 3 | 3.4 | 0 | Feb 14, 2024 | J-GAAP |
Dec, 2024 Results | 1,528 | 50 | 47 | 17 | 19.4 | 0 | Feb 14, 2025 | J-GAAP |
Revision Rate | +8.6% | +455.6% | +683.3% | +466.7% | +466.2% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Jun, 2024 | 735 | 29 | 29 | 25 | 29.2 | 0 | Aug 14, 2024 | J-GAAP |
Jan - Jun, 2025 Guidance | ー | ー | ー | ー | - | 0 | Feb 14, 2025 | J-GAAP |
YoY | - | - | - | - | - |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2023 | 1,203 | -31 | -26 | -100 | -111.5 | 0 | Feb 14, 2024 | J-GAAP |
Dec, 2024 | 1,528 | 50 | 47 | 17 | 19.4 | 0 | Feb 14, 2025 | J-GAAP |
Dec, 2025 Guidance | 1,861 | 85 | 75 | 48 | 53.9 | 0 | Feb 14, 2025 | J-GAAP |
YoY | +21.8% | +70.0% | +59.6% | +182.4% | +177.5% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 338 | -14 | -16 | -69 | -76.9 | -4.1 | Feb 14, 2024 | J-GAAP |
Jan - Mar, 2024 | 367 | 15 | 15 | 14 | 15.8 | 4.1 | May 14, 2024 | J-GAAP |
Apr - Jun, 2024 | 368 | 14 | 14 | 11 | 12.9 | 3.8 | Aug 14, 2024 | J-GAAP |
Jul - Sep, 2024 | 356 | 0 | 1 | 2 | 2.3 | 0.0 | Nov 14, 2024 | J-GAAP |
Oct - Dec, 2024 | 437 | 21 | 17 | -10 | -11.4 | 4.8 | Feb 14, 2025 | J-GAAP |
YoY | +29.3% | - | - | +85.5% | +85.2% |
Related Articles
Noile-Immune Biotech, Last Fiscal Year's Ordinary Profit Loss Narrows, Current period performance is undisclosed.
AEON Fantasy, The Current Fiscal Year Net Income Revised Downward to a Loss, Dividend Revised down by 5 yen
Rococo Co, Last Fiscal Year's Ordinary Profit Exceeds Expectations, 12% Increase in Ordinary Profit for The Current Fiscal Year
Scala, First Half Net Income Turns to Profit, Exceeds Full-Year Plan
kaihan, Apr-Dec (Cumulative 3Q) Net Income Loss Narrows, Oct-Dec Net Income Loss Narrows
Daikokuya Holdings, The Current Fiscal Year Net Income Loss Widened in Downward Revision
Kanamic Network, Oct-Dec (1Q) Ordinary Profit Increases by 19%
Nishimoto Co, 47% Decrease in Ordinary Profit for the Last Fiscal Year, Current period performance is undisclosed.
WATT MANN, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 4%
Sansei Landic, 1% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 1 yen